TEXAS INSTRUMENTS INC·4

Feb 6, 4:22 PM ET

BLINN MARK A 4

4 · TEXAS INSTRUMENTS INC · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Texas Instruments (TXN) Director Mark A. Blinn Exercises Options, Sells Shares

What Happened
Mark A. Blinn, a director of Texas Instruments (TXN), exercised multiple stock option tranches on Feb 5, 2026 to acquire a total of 2,572 shares for aggregate exercise costs of about $451,344 (breakdown: 628 @ $174.81 = $109,781; 540 @ $174.10 = $94,014; 767 @ $167.42 = $128,411; 637 @ $187.03 = $119,138). On the same day he sold 3,144 shares in an open-market transaction for a weighted average price of $221.58, resulting in proceeds of about $696,647. The filing shows corresponding derivative-to-stock conversions recorded at $0 (typical reporting for exercised options converting to shares).

Key Details

  • Transaction date: Feb 5, 2026 (Form 4 filed Feb 6, 2026). Filing appears timely.
  • Sales: 3,144 shares sold at a weighted average price of $221.58 (range reported $221.00–$221.93). Issuer will provide a detailed price-by-price breakout on request (Footnote F1).
  • Option exercises: 2,572 shares exercised across four option tranches with exercise prices of $174.81, $174.10, $167.42 and $187.03 (Footnotes F5–F8 describe vesting schedule for the options).
  • Shares owned after transaction: not disclosed in the provided excerpt of the filing.
  • Trust/ownership notes: several footnotes indicate some shares are held in trusts for family members or held in trust for the reporting person with disclaimers of beneficial ownership or trustee status (F2–F4).
  • No 10b5-1 plan, tax-withholding, or late-filing flag is indicated in the provided details.

Context
This is a common insider pattern: exercising vested options and selling shares the same day. The zero-dollar derivative dispositions reflect conversion of options into shares. Because the sale quantity (3,144) exceeds the exercised shares (2,572), Blinn likely sold a mix of newly exercised shares and previously held shares or trust-held shares; the filing’s footnotes clarify some shares are held in trusts. These transactions are factual disclosures and do not, by themselves, indicate Blinn’s longer-term view on TXN.

Insider Transaction Report

Form 4
Period: 2026-02-05
BLINN MARK A
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-05$174.81/sh+628$109,78112,870 total
  • Exercise/Conversion

    Common Stock

    2026-02-05$174.10/sh+540$94,01413,410 total
  • Exercise/Conversion

    Common Stock

    2026-02-05$167.42/sh+767$128,41114,177 total
  • Exercise/Conversion

    Common Stock

    2026-02-05$187.03/sh+637$119,13814,814 total
  • Sale

    Common Stock

    [F1]
    2026-02-05$221.58/sh3,144$696,64711,670 total
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F5]
    2026-02-056280 total
    Exercise: $174.81Exp: 2032-01-27Common Stock (628 underlying)
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F6]
    2026-02-05540540 total
    Exercise: $174.10Exp: 2033-01-26Common Stock (540 underlying)
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F7]
    2026-02-057671,533 total
    Exercise: $167.42Exp: 2034-01-25Common Stock (767 underlying)
  • Exercise/Conversion

    NQ Stock Option (Right to Buy)

    [F8]
    2026-02-056371,914 total
    Exercise: $187.03Exp: 2035-01-27Common Stock (637 underlying)
Holdings
  • Common Stock

    [F2]
    (indirect: By Trust)
    3,046
  • Common Stock

    [F3]
    (indirect: By Trust)
    6,000
  • Common Stock

    [F4]
    (indirect: By Trust)
    6,000
Footnotes (8)
  • [F1]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $221.00 to $221.93. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
  • [F2]Shares held in Trust for the benefit of family member; reporting person shares investment control. Beneficial ownership by reporting person disclaimed.
  • [F3]Shares held in Trust for the benefit of family member of which reporting person is trustee. Beneficial ownership by reporting person disclaimed.
  • [F4]Shares held in Trust for the benefit of the reporting person. Reporting person is the sole trustee.
  • [F5]The option became exercisable in four equal annual installments beginning on January 27, 2023.
  • [F6]The option became exercisable in four equal annual installments beginning on January 26, 2024.
  • [F7]The option became exercisable in four equal annual installments beginning on January 25, 2025.
  • [F8]The option became exercisable in four equal annual installments beginning on January 27, 2026.
Signature
/s/ Shannon Thompson, Attorney in Fact|2026-02-06

Documents

1 file
  • 4
    wk-form4_1770412934.xmlPrimary

    FORM 4